Q2 2026 report
Skokowy wzrost przychodów r/r (+130% w II kw. 2026, +74% narastająco za I półrocze) napędzany głównie sprzedażą towarów, a nie produktów własnych — struktura wzrostu wymaga obserwacji.
Sentiment
Neutral
No guidance change
COS
Q2 2026 report
Revenue
7.28 m PLN
— YoY
Net income
1.91 m PLN
— YoY
EBITDA
2.36 m PLN
— YoY
FCF
0.28 m PLN
— YoY
Summary
Investment thesis
- Grupa wyszła na plus operacyjnie i netto w II kwartale (EBIT 2,05 mln zł, zysk netto 1,91 mln zł) po serii kwartałów strat, ale narastająco za półrocze wynik jest ledwie dodatni (0,12 mln zł) i wrażliwy na wahania.
- Przepływy operacyjne narastająco za I półrocze wciąż ujemne (-0,79 mln zł), mimo dodatniego wyniku netto — poprawa wyniku księgowego nie przekłada się jeszcze w pełni na gotówkę.
- Kapitał własny grupy (6,34 mln zł) w dużej mierze oparty na wartości firmy i innych wartościach niematerialnych (8,13 mln zł) — po ich wyłączeniu kapitał materialny jest ujemny (-1,79 mln zł).
- Nowe zezwolenie URPL na surowiec farmaceutyczny z konopi oraz umowa z Portocanna otwierają nowy kanał przychodowy w segmencie farmaceutycznym, ale materializacja przychodów zależy od dalszych pozwoleń i importu zaplanowanego na III kw. 2026.
Read the full analysis
Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.
Financials
BETA
COS · Q2 2026
| Metric | Q2 2026 | Q2 2025 | Δ YoY | YTD 2026 | Δ YoY | Value type | Segment | Conf. |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.28 | — | — | 10.59 | — | reported | — | 1.00 |
| EBITDA | 2.36 | — | — | 0.56 | — | derived | — | 0.90 |
| EBIT | 2.05 | — | — | 0.23 | — | reported | — | 1.00 |
| EBT | 1.91 | — | — | 0.12 | — | reported | — | 1.00 |
| Net income | 1.91 | — | — | 0.12 | — | reported | — | 1.00 |
| D&A | 0.3 | — | — | 0.33 | — | reported | — | 1.00 |
| Interest expense | 0.01 | — | — | 0.02 | — | reported | — | 1.00 |
| Income tax | 0 | — | — | 0 | — | reported | — | 1.00 |
| EBITDA margin | 32.36% | — | — | 5.29% | — | derived | — | 0.90 |
| EBIT margin | 28.22% | — | — | 2.17% | — | derived | — | 0.90 |
| Net margin | 26.18% | — | — | 1.14% | — | derived | — | 0.90 |
| Cash | 0.39 | — | — | — | — | reported | — | 1.00 |
| Equity | 6.34 | — | — | — | — | reported | — | 1.00 |
| Total assets | 20.94 | — | — | — | — | reported | — | 1.00 |
| Working capital | 0.14 | — | — | — | — | derived | — | 0.90 |
| Current assets | 11.03 | — | — | — | — | reported | — | 1.00 |
| Current liabilities | 10.89 | — | — | — | — | reported | — | 1.00 |
| Non-current liabilities | 3.42 | — | — | — | — | reported | — | 1.00 |
| Inventory | 6.64 | — | — | — | — | reported | — | 1.00 |
| Trade receivables | 3.97 | — | — | — | — | reported | — | 1.00 |
| Goodwill | 8.13 | — | — | — | — | reported | — | 1.00 |
| Tangible equity | -1.79 | — | — | — | — | derived | — | 0.90 |
| CFO | 0.29 | — | — | -0.79 | — | reported | — | 1.00 |
| CapEx | 0.01 | — | — | 0.15 | — | reported | — | 1.00 |
| FCF | 0.28 | — | — | -0.94 | — | derived | — | 0.90 |
| FCF conversion | 11.73% | — | — | -167.26% | — | derived | — | 0.80 |
| CFO conversion | 12.26% | — | — | -140.47% | — | derived | — | 0.80 |
| Current ratio | 1.01x | — | — | — | — | derived | — | 0.90 |
| Quick ratio | 0.4x | — | — | — | — | derived | — | 0.90 |
| Cash ratio | 0.04x | — | — | — | — | derived | — | 0.90 |
| Interest coverage | — | — | — | 11.81x | — | derived | — | 0.80 |
| Revenue growth (YoY) | 130.24% | — | — | 73.83% | — | derived | — | 0.90 |
| Revenue growth (QoQ) | 119.83% | — | — | — | — | derived | — | 0.70 |
| EBITDA growth (YoY) | 231.94% | — | — | 114.96% | — | derived | — | 0.85 |
| EBIT growth (YoY) | 199.63% | — | — | 105.35% | — | derived | — | 0.90 |
| Net income growth (YoY) | 190.72% | — | — | 102.82% | — | derived | — | 0.90 |
| EBITDA margin Δ (YoY) | 88.84 pp | — | — | — | — | derived | — | 0.85 |
| Net margin Δ (YoY) | 92.64 pp | — | — | — | — | derived | — | 0.85 |
Q2 2026 · Δ YoY
Revenue
7.28
—
7.28
—
- Q2 2025
- —
- YTD 2026
- 10.59
- Δ YoY
- —
EBITDA
2.36
—
2.36
—
- Q2 2025
- —
- YTD 2026
- 0.56
- Δ YoY
- —
EBIT
2.05
—
2.05
—
- Q2 2025
- —
- YTD 2026
- 0.23
- Δ YoY
- —
EBT
1.91
—
1.91
—
- Q2 2025
- —
- YTD 2026
- 0.12
- Δ YoY
- —
Net income
1.91
—
1.91
—
- Q2 2025
- —
- YTD 2026
- 0.12
- Δ YoY
- —
D&A
0.3
—
0.3
—
- Q2 2025
- —
- YTD 2026
- 0.33
- Δ YoY
- —
Interest expense
0.01
—
0.01
—
- Q2 2025
- —
- YTD 2026
- 0.02
- Δ YoY
- —
Income tax
0
—
0
—
- Q2 2025
- —
- YTD 2026
- 0
- Δ YoY
- —
EBITDA margin
32.36%
—
32.36%
—
- Q2 2025
- —
- YTD 2026
- 5.29%
- Δ YoY
- —
EBIT margin
28.22%
—
28.22%
—
- Q2 2025
- —
- YTD 2026
- 2.17%
- Δ YoY
- —
Net margin
26.18%
—
26.18%
—
- Q2 2025
- —
- YTD 2026
- 1.14%
- Δ YoY
- —
Cash
0.39
—
0.39
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Equity
6.34
—
6.34
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total assets
20.94
—
20.94
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Working capital
0.14
—
0.14
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current assets
11.03
—
11.03
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current liabilities
10.89
—
10.89
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Non-current liabilities
3.42
—
3.42
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Inventory
6.64
—
6.64
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade receivables
3.97
—
3.97
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Goodwill
8.13
—
8.13
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Tangible equity
-1.79
—
-1.79
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
CFO
0.29
—
0.29
—
- Q2 2025
- —
- YTD 2026
- -0.79
- Δ YoY
- —
CapEx
0.01
—
0.01
—
- Q2 2025
- —
- YTD 2026
- 0.15
- Δ YoY
- —
FCF
0.28
—
0.28
—
- Q2 2025
- —
- YTD 2026
- -0.94
- Δ YoY
- —
FCF conversion
11.73%
—
11.73%
—
- Q2 2025
- —
- YTD 2026
- -167.26%
- Δ YoY
- —
CFO conversion
12.26%
—
12.26%
—
- Q2 2025
- —
- YTD 2026
- -140.47%
- Δ YoY
- —
Current ratio
1.01x
—
1.01x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Quick ratio
0.4x
—
0.4x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Cash ratio
0.04x
—
0.04x
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Interest coverage
—
—
—
—
- Q2 2025
- —
- YTD 2026
- 11.81x
- Δ YoY
- —
Revenue growth (YoY)
130.24%
—
130.24%
—
- Q2 2025
- —
- YTD 2026
- 73.83%
- Δ YoY
- —
Revenue growth (QoQ)
119.83%
—
119.83%
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBITDA growth (YoY)
231.94%
—
231.94%
—
- Q2 2025
- —
- YTD 2026
- 114.96%
- Δ YoY
- —
EBIT growth (YoY)
199.63%
—
199.63%
—
- Q2 2025
- —
- YTD 2026
- 105.35%
- Δ YoY
- —
Net income growth (YoY)
190.72%
—
190.72%
—
- Q2 2025
- —
- YTD 2026
- 102.82%
- Δ YoY
- —
EBITDA margin Δ (YoY)
88.84 pp
—
88.84 pp
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net margin Δ (YoY)
92.64 pp
—
92.64 pp
—
- Q2 2025
- —
- YTD 2026
- —
- Δ YoY
- —